Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

ICU Medical stock

ICUI
US44930G1076
894139

Price

156.89
Today +/-
+2.11
Today %
+1.41 %

ICU Medical stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the ICU Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the ICU Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the ICU Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze ICU Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

ICU Medical Stock Price History

DateICU Medical Price
12/24/2024156.89 undefined
12/23/2024154.70 undefined
12/20/2024156.82 undefined
12/19/2024153.20 undefined
12/18/2024154.07 undefined
12/17/2024157.17 undefined
12/16/2024159.06 undefined
12/13/2024161.64 undefined
12/12/2024165.59 undefined
12/11/2024166.19 undefined
12/10/2024160.11 undefined
12/9/2024161.31 undefined
12/6/2024155.74 undefined
12/5/2024155.65 undefined
12/4/2024156.63 undefined
12/3/2024156.64 undefined
12/2/2024160.96 undefined
11/29/2024163.96 undefined
11/27/2024159.75 undefined

ICU Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into ICU Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by ICU Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects ICU Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of ICU Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into ICU Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing ICU Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on ICU Medical’s growth potential.

ICU Medical Revenue, EBIT and net profit per share

DateICU Medical RevenueICU Medical EBITICU Medical Net Income
2028e2.41 B undefined0 undefined319.11 M undefined
2027e2.33 B undefined0 undefined262.93 M undefined
2026e2.44 B undefined344.1 M undefined213.24 M undefined
2025e2.37 B undefined329.05 M undefined178.03 M undefined
2024e2.36 B undefined285.17 M undefined139.87 M undefined
20232.26 B undefined64.08 M undefined-29.66 M undefined
20222.28 B undefined28.5 M undefined-74.3 M undefined
20211.32 B undefined141.4 M undefined103.1 M undefined
20201.27 B undefined125.6 M undefined86.9 M undefined
20191.27 B undefined193.7 M undefined101 M undefined
20181.4 B undefined176.8 M undefined28.8 M undefined
20171.29 B undefined64.7 M undefined68.6 M undefined
2016379.4 M undefined99 M undefined63.1 M undefined
2015341.7 M undefined81.9 M undefined45 M undefined
2014309.3 M undefined44.1 M undefined26.3 M undefined
2013313.7 M undefined53.3 M undefined40.4 M undefined
2012316.9 M undefined61.3 M undefined41.3 M undefined
2011302.2 M undefined48.5 M undefined44.7 M undefined
2010283 M undefined47.7 M undefined29.9 M undefined
2009229 M undefined35.4 M undefined25 M undefined
2008204.7 M undefined31.4 M undefined24.3 M undefined
2007188.1 M undefined24.6 M undefined23.1 M undefined
2006201.6 M undefined28.8 M undefined25.7 M undefined
2005157.5 M undefined27.6 M undefined20.3 M undefined
200475.6 M undefined5.9 M undefined5 M undefined

ICU Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
00.010.010.010.010.020.020.020.030.040.050.060.070.090.110.080.160.20.190.20.230.280.30.320.310.310.340.381.291.41.271.271.322.282.262.362.372.442.332.41
-66.6740.0042.8610.0045.4531.2514.2925.0030.0020.5119.1523.2126.0922.99-29.91109.3328.03-6.478.5112.2523.586.714.64-0.95-1.2810.3611.14240.908.36-9.570.393.5473.25-0.924.380.343.00-4.553.44
33.3360.0071.4360.0063.6443.7552.3858.3356.6758.9757.4557.1457.9758.6254.2146.6743.9539.8041.4943.6346.2945.5847.0249.3749.2048.8752.7953.0332.9740.7137.2036.2737.3130.5732.7131.3431.2330.3231.7730.71
135677111417232732405158356980788910612914215615415118020142657047146149169773900000
01343244579111519225202523242529444140264563682810186103-74-29139178213262319
--200.0033.33-25.00-33.33100.00-25.0040.0028.5722.2236.3626.6715.79-77.27300.0025.00-8.004.354.1716.0051.72-6.82-2.44-35.0073.0840.007.94-58.82260.71-14.8519.77-171.84-60.81-579.3128.0619.6623.0021.76
7.57.68.210.411.110.912.113.31212.61313.614.515.415.1151515.615.314.61513.914.214.715.315.616.517.320.921.621.521.621.823.924.0900000
----------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The ICU Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the ICU Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
1990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                                   
22.415.516.38.130.231.835.138.138.450.87388.573.187.386.7116.995.6111.8108.193.4160226.2296.9346.8377.4445.1300.1382.1292.6410.8567.2213254.72
0.90.81.41.62.22.733.46.57.112.413.116.624.98.923.626.526.138.447.850.943.649.145.339.157.856.2112.7176.3202.2124.1105.9221.7161.57
00000000000005.89.254.62.84.622.35.62.363.914.412.2117.536.620.23.74.23.62.75
0.70.40.61.22.91.52.21.822.11.41.65.73.48.415.416.319.517.941.344.140.436.334.536.943.649.3288.7311.2337.6314.9290.2696709.36
00.10.20.91.11.41.30.91.41.72.62.73.43.93.277.29.26.78.714.710.911.611.710.511.76.345.720.929.667.362.3100.992.88
000.020.020.010.040.040.040.050.050.070.090.110.110.120.140.170.150.180.210.210.260.330.390.440.50.570.860.930.880.921.031.241.22
0.50.61.13.411.711.710.99.613.824.423.925.134.64140.952.25972.769.977.483.58385.987.986.174.385.7398.7432.6490.6513.2508.2713.6685.53
00000000000000000011.40000000014.620134.63.73.12
00000000000004.83.62.401.81.20.900000000000000
000000.30.40.40.50.40.40.33.44.22.8119.811.910.816.814.811.4108.57.123.922.4143.8133.4211.4197.2188.3982.8870.59
00000000000000000000000000.010.010.010.010.030.030.041.451.47
0.10.10.10.20.30.10.10.10.11.11.41.54.93.10.41.242.910.84.74.64.85.67.59.317.121.962.979.17786.5106.3131.2125.49
00000.010.010.010.010.010.030.030.030.040.050.050.070.070.090.10.10.10.10.10.110.10.120.140.630.660.810.840.853.283.16
000.020.020.030.050.050.050.060.080.090.120.160.160.160.20.240.240.280.310.310.360.430.50.540.630.71.51.591.691.761.884.524.38
                                                                   
3.30.30.50.70.70.90.90.90.90.90.90.91.41.41.41.41.51.51.51.51.51.51.51.51.61.61.6222.12.12.12.42.41
0.010.010.020.020.020.040.040.040.040.040.040.050.060.060.060.060.070.070.050.050.060.060.060.080.110.150.160.630.660.670.690.721.331.37
-11.5-8.5-3.6-0.32.66.811.316.924.233.445.66180.7103108128.3153.9177201.3227.9256.2300.9342.2382.6408.9453.9517585.6620.7721.8808.7911.8837.5807.85
00000000000000.20.500.41.40.91.2-1.1-3.2-1.42.2-9.6-20.8-21.3-15-16.9-17.3-4.3-19-121.8-74.97
000000000000000000000000000001.92.8-0.240.821.88
-000.020.020.020.050.050.060.070.080.090.110.150.170.170.190.230.250.250.290.310.360.410.460.510.580.661.21.261.381.51.622.092.12
0.40.30.40.70.811.91.40.711.72.453.12.75.18.18.47.918.410.913.311.311.311.413.714.678.2120.5128.671.981.1215.9150.03
0.30.20.50.60.80.90.512.64.15.36.35.15.24.88.87.81314.112.914.616.117.815.617.428.925.9128.7125111.390.9104.9211.1235.72
6.21.90.60.8000.20.70.82.32.51.91.50000002.40.30000003.33.88.532.214.13744.23
0000000000000000000000000000000000
0000000000000000000000000000000.60.630.551.86
6.92.41.52.11.61.92.63.14.17.49.510.611.68.37.513.915.921.42233.725.829.429.126.928.842.640.5210.2249.3248.4195.6200.7494.5481.84
000000000000000000000000000000001.631.58
00000.10.20.20.100000000.53.14.345.787.15.23.61.41.41.41.50.72.11.71.512655.87
000000000000000002.94.44.84.24.13.34.42.732.686.971.764.661.960.4179.6137.59
000000000000000000.010.010.010.010.010.010.010000.090.070.070.070.061.931.77
0.01000000000.010.010.010.010.010.010.010.020.030.030.040.040.040.040.030.030.050.040.30.320.320.260.262.432.26
000.020.020.030.050.050.060.070.080.10.120.160.180.180.20.250.280.290.330.350.40.440.50.540.630.71.51.591.691.761.884.524.38
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of ICU Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand ICU Medical's financial health and stability.

Assets

ICU Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that ICU Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of ICU Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into ICU Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
01343244579111519225202523242529444140264563682810186103-74-29
0000011222345578911111415171819191918196674768589235228
0000000000-10001-110000000-6-1-70-24-204-180-66-82
000-10-3001-22-20-7-89-8-25-105-199-234-18-980-5-116114-237-53
000000000000310034-21478-41314213031-17106579187116143
0000000000000000000000000000200106395
00000211234651141447391520161282321512931192735
0233307686151324282225273141305133646665605489154160101222267-62166
0000-3-9-1-10-6-14-4-6-11-10-7-38-19-26-11-46-23-15-20-19-17-13-24-79-100-106-100-81-99-93
000-13-3-2-22-2-3-10-15-16-26-36-12-14-33-34-103-3719-45-41-13-21-1116-266-103-166-98-90-1,909-87
000-1207-20-1-2-30-12-20-24-1-74-141615842-29-216-4240-187-2-602-9-1,8105
00000000000000000000000000000000000
00-00000000000000000000000000-0.0800001.64-0.03
000100016-3-430248-12-672-375-17-24-2171713152308-1001-24
00-00.01000.02-0-000000.01-0.01-0.010.010.01-0.040.01-0.02-0.0200.020.020.020.030-0.040.01-0.010-0.021.64-0.04
00000000000000000609014475900000-17-2-9
00000000000000000000000000000000000
01000-110000010-2316-547-4272047794960108-15554-76127156-34445
0.21.72.72.30.2-8.55.35.27.9-0.10.79.518.116.212.118.2-10.71214.618.859.948.74646.2434165.374.759.4-4.1122.4186.3-161.472.53
00000000000000000000000000000000000

ICU Medical stock margins

The ICU Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ICU Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ICU Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the ICU Medical's sales revenue. A higher gross margin percentage indicates that the ICU Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the ICU Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the ICU Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the ICU Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the ICU Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the ICU Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

ICU Medical Margin History

ICU Medical Gross marginICU Medical Profit marginICU Medical EBIT marginICU Medical Profit margin
2028e32.75 %0 %13.26 %
2027e32.75 %0 %11.3 %
2026e32.75 %14.12 %8.75 %
2025e32.75 %13.91 %7.52 %
2024e32.75 %12.09 %5.93 %
202332.75 %2.84 %-1.31 %
202230.61 %1.25 %-3.26 %
202137.34 %10.74 %7.83 %
202036.31 %9.88 %6.84 %
201937.27 %15.3 %7.98 %
201840.71 %12.63 %2.06 %
201732.96 %5.01 %5.31 %
201653.08 %26.09 %16.63 %
201552.91 %23.97 %13.17 %
201448.95 %14.26 %8.5 %
201349.31 %16.99 %12.88 %
201249.38 %19.34 %13.03 %
201147.12 %16.05 %14.79 %
201045.58 %16.86 %10.57 %
200946.42 %15.46 %10.92 %
200843.87 %15.34 %11.87 %
200741.57 %13.08 %12.28 %
200640.03 %14.29 %12.75 %
200544.06 %17.52 %12.89 %
200447.22 %7.8 %6.61 %

ICU Medical Stock Sales Revenue, EBIT, Earnings per Share

The ICU Medical earnings per share therefore indicates how much revenue ICU Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue ICU Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates ICU Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of ICU Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating ICU Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

ICU Medical Revenue, EBIT and net profit per share

DateICU Medical Sales per ShareICU Medical EBIT per shareICU Medical Earnings per Share
2028e98.28 undefined0 undefined13.04 undefined
2027e95.02 undefined0 undefined10.74 undefined
2026e99.55 undefined0 undefined8.71 undefined
2025e96.65 undefined0 undefined7.27 undefined
2024e96.32 undefined0 undefined5.71 undefined
202393.77 undefined2.66 undefined-1.23 undefined
202295.4 undefined1.19 undefined-3.11 undefined
202160.38 undefined6.49 undefined4.73 undefined
202058.84 undefined5.81 undefined4.02 undefined
201958.89 undefined9.01 undefined4.7 undefined
201864.81 undefined8.19 undefined1.33 undefined
201761.85 undefined3.1 undefined3.28 undefined
201621.93 undefined5.72 undefined3.65 undefined
201520.71 undefined4.96 undefined2.73 undefined
201419.83 undefined2.83 undefined1.69 undefined
201320.5 undefined3.48 undefined2.64 undefined
201221.56 undefined4.17 undefined2.81 undefined
201121.28 undefined3.42 undefined3.15 undefined
201020.36 undefined3.43 undefined2.15 undefined
200915.27 undefined2.36 undefined1.67 undefined
200814.02 undefined2.15 undefined1.66 undefined
200712.29 undefined1.61 undefined1.51 undefined
200612.92 undefined1.85 undefined1.65 undefined
200510.5 undefined1.84 undefined1.35 undefined
20045.04 undefined0.39 undefined0.33 undefined

ICU Medical business model

ICU Medical Inc is a US medical technology company specializing in the development and production of innovative products for infusion and oncology therapy. It was founded in 1984 by Dr. George A. Lopez and has become a leading manufacturer of disposable products for infusion therapy. The company offers a wide range of disposable products for infusion and oncology therapy, including solutions, medication administration systems, catheters, syringes, tubes, and sensors. They also manufacture medical devices such as syringe pumps, medication administration pumps, and gravity infusion devices. ICU Medical Inc collaborates with other companies in the medical and pharmaceutical industries to provide comprehensive solutions for intravenous therapy. The company's product range includes syringes, tubes, catheters, combination products, infusion and syringe pumps, and the Clave technology for closed infusion pump systems. ICU Medical is one of the most popular companies on Eulerpool.com.

ICU Medical SWOT Analysis

Strengths

ICU Medical Inc has a strong market presence and brand reputation in the medical device industry.

The company offers a wide range of innovative and high-quality medical products, meeting the diverse needs of healthcare providers.

ICU Medical Inc has a robust distribution network, enabling efficient delivery of its products worldwide.

Weaknesses

ICU Medical Inc relies heavily on a limited number of key suppliers, which could result in potential supply chain disruptions.

The company may face challenges in keeping up with rapidly evolving healthcare regulations and compliance requirements.

ICU Medical Inc has high research and development costs, which can impact its profitability.

Opportunities

The increasing global demand for healthcare services presents an opportunity for ICU Medical Inc to expand its market share.

Advancements in medical technology open doors for the development and introduction of new and improved medical devices.

ICU Medical Inc can explore strategic partnerships or acquisitions to enhance its product portfolio and market reach.

Threats

Intense competition in the medical device industry puts pressure on pricing and reduces profit margins for ICU Medical Inc.

Changes in healthcare policies and reimbursement systems can impact the demand and adoption of medical devices.

Economic downturns and fluctuations in exchange rates can affect the company's financial performance in international markets.

ICU Medical Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

ICU Medical Revenue by Segment

Segmente202320222021202020192018
Infusion Consumables969.13 M USD566.62 M USD555.19 M USD473.74 M USD-483.04 M USD
Infusion Systems629.04 M USD351.08 M USD352.32 M USD359.69 M USD-355.48 M USD
IV Solutions-363.47 M USD359.48 M USD388.97 M USD-507.99 M USD
Vital Care660.95 M USD284.61 M USD----
Infusion Consumables-Smiths Medical-340.12 M USD----
Vascular Access-326.77 M USD----
Critical Care-47.33 M USD49.32 M USD48.6 M USD-53.53 M USD
Other Revenue------

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

ICU Medical Revenue by Segment

Segmente202320222021202020192018
Infusion Consumables----477.61 M USD-
IV Solutions----414.97 M USD-
Infusion Systems----328.28 M USD-
Critical Care----45.34 M USD-
Other Revenue------

ICU Medical Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

ICU Medical Revenue by Segment

DateAPAC [Domain]Asia PacificCANADAEMEAEuropeForeignOther foreign countriesOther LATAMUnited States
2023241.7 M USD--373.57 M USD--203.84 M USD-1.44 B USD
2022257.21 M USD--367.41 M USD--195.31 M USD-1.46 B USD
2021---147.49 M USD-374.5 M USD227.01 M USD-941.81 M USD
2020---132.76 M USD-360.38 M USD227.61 M USD-910.63 M USD
2019---130.53 M USD-342.87 M USD212.34 M USD-923.34 M USD
2018---134.36 M USD-345.36 M USD211 M USD-1.05 B USD
2017-54.47 M USD69.75 M USD-100.42 M USD312.68 M USD30.18 M USD57.85 M USD979.94 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

ICU Medical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

ICU Medical historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

ICU Medical shares outstanding

The number of shares was ICU Medical in 2023 — This indicates how many shares 24.091 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue ICU Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates ICU Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of ICU Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating ICU Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

ICU Medical stock splits

In ICU Medical's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for ICU Medical.

ICU Medical latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20241.28 1.59  (24.68 %)2024 Q3
6/30/20241.02 1.56  (53.21 %)2024 Q2
3/31/20240.84 0.96  (14.78 %)2024 Q1
12/31/20231.22 1.57  (29.08 %)2023 Q4
9/30/20231.41 1.57  (11.13 %)2023 Q3
6/30/20231.63 1.88  (15.2 %)2023 Q2
3/31/20231.46 1.74  (19.57 %)2023 Q1
12/31/20221.59 1.6  (0.55 %)2022 Q4
9/30/20221.49 1.75  (17.25 %)2022 Q3
6/30/20221.69 1.37  (-19.09 %)2022 Q2
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the ICU Medical stock

Eulerpool World ESG Rating (EESG©)

46/ 100

🌱 Environment

22

👫 Social

64

🏛️ Governance

53

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

ICU Medical shareholders

%
Name
Stocks
Change
Date
12.10698 % BlackRock Institutional Trust Company, N.A.2,963,789563,5616/30/2024
10.47849 % The Vanguard Group, Inc.2,565,134116,8946/30/2024
9.98205 % Janus Henderson Investors2,443,605-27,8916/30/2024
6.20578 % Fuller & Thaler Asset Management Inc.1,519,174-15,5686/30/2024
5.89373 % Wellington Management Company, LLP1,442,78663,5966/30/2024
4.88193 % Lopez (George A)1,195,096-54,9673/19/2024
3.39094 % State Street Global Advisors (US)830,101120,3086/30/2024
2.90062 % JP Morgan Asset Management710,072-53,2736/30/2024
2.63435 % Schroder Investment Management North America Inc.644,88832,7456/30/2024
2.43752 % Neuberger Berman, LLC596,70412,5356/30/2024
1
2
3
4
5
...
10

ICU Medical Executives and Management Board

Mr. Vivek Jain

(51)
ICU Medical Chairman of the Board, Chief Executive Officer (since 2014)
Compensation 5.66 M

Mr. Christian Voigtlander

(55)
ICU Medical Chief Operating Officer
Compensation 3.65 M

Mr. Brian Bonnell

(49)
ICU Medical Chief Financial Officer, Treasurer
Compensation 3.62 M

Ms. Virginia Sanzone

(48)
ICU Medical Corporate Vice President, General Counsel, Secretary
Compensation 2.05 M

Mr. Daniel Woolson

(46)
ICU Medical Corporate Vice President, General Manager - Infusion Systems
Compensation 1.84 M
1
2
3

ICU Medical Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
GVS Stock
GVS
SupplierCustomer0,810,580,480,36-0,14-0,12
Covetrus Inc Stock
Covetrus Inc
SupplierCustomer0,64-0,540,040,29-0,36-0,26
InfuSystem Stock
InfuSystem
SupplierCustomer0,37-0,170,580,39-0,040,02
Analytica Stock
Analytica
SupplierCustomer0,210,510,580,44-0,28
Vocera Communications, Inc. Stock
Vocera Communications, Inc.
SupplierCustomer0,09-0,86-0,66-0,54-0,08
Pfizer Stock
Pfizer
SupplierCustomer-0,040,810,020,120,200,57
DCC Stock
DCC
SupplierCustomer-0,180,28-0,47-0,24-0,02-0,12
Model N Stock
Model N
SupplierCustomer-0,540,740,590,600,10-0,30
1

Most common questions regarding ICU Medical

What values and corporate philosophy does ICU Medical represent?

ICU Medical Inc represents the values of innovation, quality, and patient safety. With a commitment to advancing healthcare, the company focuses on developing and delivering innovative medical devices and solutions. ICU Medical Inc's corporate philosophy emphasizes collaboration, integrity, and a patient-centric approach. By consistently meeting the highest standards of excellence, the company strives to improve patient outcomes and enhance the overall healthcare experience. With a strong emphasis on research and development, ICU Medical Inc is dedicated to providing healthcare professionals with cutting-edge technologies that support optimal patient care.

In which countries and regions is ICU Medical primarily present?

ICU Medical Inc is primarily present in the United States, with its headquarters located in San Clemente, California. In addition to its strong presence in the domestic market, ICU Medical Inc operates in various other countries and regions across the globe. The company has offices and facilities in Europe, including Germany, France, and the United Kingdom, as well as in the Asia-Pacific region, with locations in Australia, China, and Japan. With a global reach, ICU Medical Inc is able to serve healthcare institutions and providers worldwide, offering innovative medical technologies and solutions.

What significant milestones has the company ICU Medical achieved?

ICU Medical Inc., a leading global provider of medical devices, has achieved several significant milestones over the years. One notable achievement is the acquisition of Hospira Infusion Systems from Pfizer in 2017. This strategic acquisition expanded ICU Medical's product portfolio and strengthened its position in the infusion therapy market. Additionally, ICU Medical Inc. received FDA clearance for its innovative Clave™ Needlefree Connector, which has revolutionized intravenous therapy by reducing the risk of infections. Furthermore, the company has consistently demonstrated strong financial performance, marked by revenue growth and profitability. With a commitment to innovation and quality, ICU Medical Inc. continues to make strides in improving patient care and addressing critical healthcare challenges.

What is the history and background of the company ICU Medical?

ICU Medical Inc. is a renowned company in the healthcare industry. Established in 1984, ICU Medical has a rich history of delivering innovative medical devices and solutions. The company provides a wide range of products, including infusion therapy, critical care, and oncology systems, designed to enhance patient safety and improve medical outcomes. ICU Medical has grown significantly over the years and has become a global leader in infusion therapy technology. With a commitment to quality and continuous innovation, ICU Medical continues to play a vital role in revolutionizing the healthcare sector and improving patient care worldwide.

Who are the main competitors of ICU Medical in the market?

The main competitors of ICU Medical Inc in the market include Becton, Dickinson and Company, Fresenius Kabi AG, and Baxter International Inc.

In which industries is ICU Medical primarily active?

ICU Medical Inc is primarily active in the healthcare industry.

What is the business model of ICU Medical?

ICU Medical Inc is a healthcare company that specializes in the development, manufacture, and sale of medical devices, consumables, and services. Its business model revolves around providing innovative and cost-effective solutions to improve patient care and safety. ICU Medical Inc focuses on critical care, oncology, and infusion therapy markets, offering products like infusion pumps, needle-free connectors, and custom infusion sets. By collaborating with healthcare professionals and maintaining a customer-centric approach, the company aims to enhance patient outcomes and streamline healthcare delivery. ICU Medical Inc's commitment to innovation, quality, and customer satisfaction drives its business strategy and growth in the healthcare industry.

What is the P/E ratio of ICU Medical 2024?

The ICU Medical P/E ratio is 27.02.

What is the P/S ratio of ICU Medical 2024?

The ICU Medical P/S ratio is 1.6.

What is the Quality Investing of ICU Medical?

The Quality Investing for ICU Medical is 2/10.

What is the revenue of ICU Medical 2024?

The expected ICU Medical revenue is 2.36 B USD.

How high is the profit of ICU Medical 2024?

The expected ICU Medical profit is 139.87 M USD.

What is the business model of ICU Medical

ICU Medical Inc is a globally operating company specializing in the development and manufacturing of innovative medical products. The company serves various sectors such as infusion therapy, oncology, and intensive care medicine. With its extensive portfolio of products, ICU Medical Inc aims to contribute to improving patient care worldwide.

What is the ICU Medical dividend?

ICU Medical pays a dividend of 0 USD distributed over payouts per year.

How often does ICU Medical pay dividends?

The dividend cannot currently be calculated for ICU Medical or the company does not pay out a dividend.

What is the ICU Medical ISIN?

The ISIN of ICU Medical is US44930G1076.

What is the ICU Medical WKN?

The WKN of ICU Medical is 894139.

What is the ICU Medical ticker?

The ticker of ICU Medical is ICUI.

How much dividend does ICU Medical pay?

Over the past 12 months, ICU Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ICU Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of ICU Medical?

The current dividend yield of ICU Medical is .

When does ICU Medical pay dividends?

ICU Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ICU Medical?

ICU Medical paid dividends every year for the past 0 years.

What is the dividend of ICU Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ICU Medical located?

ICU Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von ICU Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ICU Medical from 12/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/26/2024.

When did ICU Medical pay the last dividend?

The last dividend was paid out on 12/26/2024.

What was the dividend of ICU Medical in the year 2023?

In the year 2023, ICU Medical distributed 0 USD as dividends.

In which currency does ICU Medical pay out the dividend?

The dividends of ICU Medical are distributed in USD.

All fundamentals about ICU Medical

Our stock analysis for ICU Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ICU Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.